CKD-393

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Type 2 DiabetesType II Diabetes Mellitus

Phase 1

Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393

CompletedNCT05113693

Chong Kun Dang PharmaceuticalType 2 Diabetes

Start: 2021-11-25End: 2021-12-10Updated: 2023-06-09

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

CompletedNCT05274880

Chong Kun Dang PharmaceuticalType II Diabetes Mellitus

Start: 2022-06-21End: 2022-07-26Updated: 2022-11-30